{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:55:13Z","timestamp":1791417313376,"version":"4.3.3"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1097\/mop.0b013e32834fdc3a","type":"journal-article","created":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T07:34:43Z","timestamp":1325835283000},"page":"252-258","source":"Crossref","is-referenced-by-count":104,"title":["Neonatal abstinence syndrome"],"prefix":"10.1097","volume":"24","author":[{"given":"Lauren M.","family":"Jansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-19-20210206","doi-asserted-by":"crossref","first-page":"259e1","DOI":"10.1016\/j.ajog.2010.12.050","article-title":"Current trends in narcotic use in pregnancy and neonatal outcomes.","volume":"204","author":"Kellog","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R2-19-20210206","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa1005359","article-title":"Neonatal abstinence syndrome following methadone or buprenorphine exposure.","volume":"363","author":"Jones","year":"2010","journal-title":"New Engl J Med"},{"key":"R3-19-20210206","first-page":"73","article-title":"Indicators of buprenorphine and methadone use and abuse: what do we know Am J A","volume":"19","author":"Maxwell","year":"2010","journal-title":"ddict"},{"key":"R4-19-20210206","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/10550490903077820","article-title":"Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.","volume":"18","author":"Gwin Mitchell","year":"2009","journal-title":"Am J Addict"},{"key":"R5-19-20210206","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/jp.2010.211","article-title":"Long-term outcome following selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.","volume":"31","author":"Klinger","year":"2011","journal-title":"J Perinatol"},{"key":"R7-19-20210206","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-3476(77)80387-9","article-title":"Withdrawal symptoms in infants with the fetal alcohol syndrome.","volume":"90","author":"Pierog","year":"1977","journal-title":"J Pediatr"},{"key":"R8-19-20210206","first-page":"485","article-title":"Symptoms of neonatal ethanol withdrawal.","volume":"8","author":"Robe","year":"1981","journal-title":"Curr Alcohol"},{"key":"R9-19-20210206","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/pds.1457","article-title":"Use of benzodiazepines and benzodiazepine agonists during pregnancy: neonatal outcome and congenital malformations.","volume":"16","author":"Wikner","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R10-19-20210206","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1176\/appi.ps.53.1.39","article-title":"Effects of commonly used benzodiazepines on the fetus, the neonate and the nursing infant.","volume":"53","author":"Iqbal","year":"2002","journal-title":"Psychiatr Serv"},{"key":"R11-19-20210206","first-page":"288","article-title":"In utero exposure to smoking and newborn neurobehavior: how to assess neonatal withdrawal syndrome Ther Drug M","volume":"28","author":"Pichini","year":"2006","journal-title":"onit"},{"key":"R12-19-20210206","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1017\/S1092852900027449","article-title":"On categorizing gestational, birth and neonatal complications following late pregnancy exposure to antidepressants: the prenatal antidepressant exposure syndrome.","volume":"15","author":"Gentile","year":"2010","journal-title":"CNS Spectr"},{"key":"R14-19-20210206","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10826089609045811","article-title":"Neonatal withdrawal syndrome in infants exposed to cocaine and methadone.","volume":"31","author":"Mayes","year":"1996","journal-title":"Subst Use Misuse"},{"key":"R15-19-20210206","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.drugalcdep.2004.03.012","article-title":"Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure.","volume":"75","author":"Choo","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"R18-19-20210206","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsat.2006.06.015","article-title":"Mood disorders affect drug treatment success of drug-dependent pregnant women.","volume":"32","author":"Fitzsimons","year":"2007","journal-title":"J Subst Abuse Treat"},{"key":"R19-19-20210206","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06037.x","article-title":"Behavioral epigenetics.","volume":"1226","author":"Lester","year":"2011","journal-title":"Ann NY Acad Sci"},{"key":"R21-19-20210206","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4088\/JCP.v65n0214","article-title":"Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.","volume":"65","author":"Oberlander","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"R22-19-20210206","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R23-19-20210206","first-page":"107","article-title":"Selective serotonin reuptake inhibitor induced neonatal abstinence syndrome.","volume":"45","author":"Klinger","year":"2008","journal-title":"Isr J Psychiatry Relat Sci"},{"key":"R24-19-20210206","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3109\/00207450802338697","article-title":"Prenatal depression and selective serotonin reuptake inhibitors.","volume":"120","author":"Field","year":"2010","journal-title":"Int J Neurosci"},{"key":"R25-19-20210206","doi-asserted-by":"crossref","first-page":"e12201","DOI":"10.1371\/journal.pone.0012201","article-title":"Prenatal exposure to maternal depressed mood and the MTHFR C677T variant affect SLC6A4 methylation in infants at birth.","volume":"5","author":"Devlin","year":"2010","journal-title":"PLoS One"},{"key":"R26-19-20210206","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000207491","article-title":"Third pathophysiology of prenatal cocaine exposure.","volume":"31","author":"Lester","year":"2009","journal-title":"Dev Neurosci"},{"key":"R27-19-20210206","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.clp.2009.06.002","article-title":"Fetal effects of psychoactive drugs.","volume":"36","author":"Salisbury","year":"2009","journal-title":"Clin Perinatol"},{"key":"R28-19-20210206","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14767050701490327","article-title":"Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.","volume":"20","author":"Jansson","year":"2007","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R30-19-20210206","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jsat.2005.09.001","article-title":"Exposure to violence among substance-dependent pregnant women and their children.","volume":"30","author":"Velez","year":"2006","journal-title":"J Subst Abuse Treat"},{"key":"R31-19-20210206","first-page":"29","article-title":"Prenatal programming of postnatal plasticity Dev P","volume":"23","author":"Pluess","year":"2011","journal-title":"sychopathol"},{"key":"R32-19-20210206","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00431-009-0994-0","article-title":"Neonatal abstinence syndrome postnatal ward versus neonatal unit management.","volume":"169","author":"Saiki","year":"2010","journal-title":"Eur J Pediatr"},{"key":"R33-19-20210206","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugalcdep.2008.01.025","article-title":"Buprenorphine and methadone treatment of opiate dependence during pregnancy:comparison of fetal growth and neonatal outcomes in two consecutive case series.","volume":"96","author":"Kakko","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R34-19-20210206","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drugalcdep.2005.10.001","article-title":"Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.","volume":"82","author":"Lejeune","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"Suppl 1","key":"R35-19-20210206","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000052040","article-title":"Buprenorphine maintenance in pregnant opiate addicts.","volume":"4","author":"Fischer","year":"1998","journal-title":"Eur Addict Res"},{"key":"R36-19-20210206","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ntt.2010.09.003","article-title":"Fetal neurobehavioral effects of exposure to methadone or buprenorphine.","volume":"33","author":"Jansson","year":"2010","journal-title":"Neurotoxicol Teratol"},{"key":"R38-19-20210206","first-page":"611","article-title":"Fetal response to maternal methadone administration.","volume":"193","author":"Jansson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R40-19-20210206","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.2006-2133","article-title":"Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.","volume":"119","author":"Ferreira","year":"2007","journal-title":"Pediatrics"},{"key":"R41-19-20210206","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":"Neonatal signs after late in utero exposure to serotonin reuptake inhibitors.","volume":"293","author":"Moses-Kolko","year":"2006","journal-title":"JAMA"},{"key":"R42-19-20210206","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/000992287501400613","article-title":"A proposed narcotic withdrawal score for use with newborn infants: a pragmatic valuation of its efficacy.","volume":"14","author":"Lipsitz","year":"1975","journal-title":"Clin Pediatr"},{"key":"R43-19-20210206","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/S0022-3476(76)80027-3","article-title":"A study of factors that influence the severity of neonatal withdrawal.","volume":"88","author":"Ostrea","year":"1976","journal-title":"J Pediatr"},{"key":"R44-19-20210206","first-page":"141","article-title":"Neonatal abstinence syndrome: assessment and management.","volume":"2","author":"Finnegan","year":"1975","journal-title":"Addict Dis"},{"key":"R45-19-20210206","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5055\/jom.2009.0006","article-title":"The opioid-exposed newborn: assessment and pharmacologic management.","volume":"5","author":"Jansson","year":"2009","journal-title":"J Opioid Manag"},{"key":"R46-19-20210206","first-page":"327","article-title":"Shorter dosing interval of opiate solution shortens hospital stay for methadone babies.","volume":"31","author":"Jones","year":"1999","journal-title":"Fam Med"},{"key":"R48-19-20210206","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1360-0443.2010.03170.x","article-title":"Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.","volume":"106","author":"Kraft","year":"2011","journal-title":"Addiction"},{"key":"R49-19-20210206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/15563650902980019","article-title":"Use of clonidine in the prevention and management of neonatal abstinence syndrome.","volume":"47","author":"Leikin","year":"2009","journal-title":"Clin Toxicol"},{"key":"R50-19-20210206","doi-asserted-by":"crossref","first-page":"e849","DOI":"10.1542\/peds.2008-0978","article-title":"Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial.","volume":"123","author":"Agthe","year":"2009","journal-title":"Pediatrics"},{"key":"R51-19-20210206","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1067\/mpd.2002.123099","article-title":"Diluted tincture of opium (DTO) and phenobarbital versus DTO alone for neonatal opiate withdrawal in term infants.","volume":"140","author":"Coyle","year":"2002","journal-title":"J Pediatr"},{"key":"R52-19-20210206","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1203\/PDR.0b013e3181bc035d","article-title":"Prenatal methadone exposure and neonatal neurobehavioral functioning.","volume":"66","author":"Velez","year":"2009","journal-title":"Pediatr Res"},{"key":"R53-19-20210206","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/YCO.0b013e32834776a8","article-title":"Understanding and promoting resilience in children and youth.","volume":"24","author":"Sapienza","year":"2011","journal-title":"Curr Opin Psychiatry"},{"key":"R54-19-20210206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.mp.4002007","article-title":"Infant serotonin transporter (SLC6A4) promoter genotype is associated with adverse neonatal outcomes after prenatal exposure to serotonin reuptake inhibitor medications.","volume":"13","author":"Oberlander","year":"2008","journal-title":"Mol Psychiatry"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e32834fdc3a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:04Z","timestamp":1786047964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-201204000-00019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32834fdc3a","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}